Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trialJochen H. Lorch, Marshall R. Posner, Olga Goloubeva et al.|The Lancet Oncology|2011Cited by 447
Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer PatientsKathleen Settle, Kevin J. Cullen, Mohan Suntharalingam et al.|Cancer Prevention Research|2009Cited by 297
β-Tubulin-II Expression Strongly Predicts Outcome in Patients Receiving Induction Chemotherapy for Locally Advanced Squamous Carcinoma of the Head and Neck: A Companion Analysis of the TAX 324 TrialKevin J. Cullen, Marshall R. Posner, Lisa M. Schumaker et al.|Journal of Clinical Oncology|2009Cited by 59
Novel biomarker panel predicts prognosis in human papillomavirus‐negative oropharyngeal cancerYin Wu, Kevin J. Cullen, Marshall R. Posner et al.|Cancer|2011Cited by 29
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancerAileen I. Fernandez, Rebecca B. Riggins, Xue Geng et al.|Breast Cancer Research and Treatment|2019Cited by 15